A sensitive high-performance liquid chromatographic assay for the cholecystokinin-b antagonist, CI-988, in human and monkey plasma
โ Scribed by Joanna P. Hinton; Kathleen Jennings; Elvin L. Johnson; D. Scott Wright
- Publisher
- John Wiley and Sons
- Year
- 1995
- Tongue
- English
- Weight
- 385 KB
- Volume
- 9
- Category
- Article
- ISSN
- 0269-3879
No coin nor oath required. For personal study only.
โฆ Synopsis
A sensitive and specific high-performance liquid chromatographic assay for the non-peptide cholecystokinin subtype B receptor antagonist, C1-988, in human and cynomolgus monkey plasma has been developed and validated. The method involves isolation of CI-988 and internal standard by batch robotic solid phase extraction with a C,, cartridge, liquid chromatographic separation on a CI8 column and quantitation by fluorescence detection. The human plasma assay is linear from 0.25 to 500ng/mL for a 1.00-mL plasma aliquot. Assay precision for C1-988 based on human plasma quality control samples was within +7.2% relative standard deviation with an accuracy of f5.6% relative error. The monkey plasma assay is linear from 1.00 to 250 ng/mL for a 0.500-mL plasma aliquot. Assay precision based on monkey plasma quality control samples was within i 11.0% relative standard deviation with an accuracy of *2.6% relative error.
๐ SIMILAR VOLUMES
A specific, accurate, precise, and reproducible High-performance liquid chromatographic-Ultraviolet (HPLC-W) method was developed for the simultaneous quantitation of BMS-181101 (I), a new antidepressant, and its putative metabolites, 6'-hydroxy (11) and 7'-hydroxy (111) of BMS-181101 in rat and mon
A simple and sensitive reversed-phase liquid chromatographic method has been developed and validated for the analysis of nicardipine in human plasma and the study of the pharmacokinetics of the drug in human body. Nicardipine and nimodipine (internal standard) in plasma were extracted with hexane-bu